Cargando…
Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
Although inhibitors of epigenetic regulators have been effective in the treatment of cutaneous T cell lymphoma (CTCL) and other hematopoietic malignancies, they have been less effective in solid tumors, including ovarian cancer (OC). We have previously shown that inhibition of histone deacetylase (H...
Autores principales: | Gatla, Himavanth R., Zou, Yue, Uddin, Mohammad M., Vancurova, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642595/ https://www.ncbi.nlm.nih.gov/pubmed/29050320 http://dx.doi.org/10.18632/oncotarget.19990 |
Ejemplares similares
-
Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
por: Uddin, Mohammad M., et al.
Publicado: (2018) -
HDAC/IKK inhibition therapies in solid tumors
por: Vancurova, Ivana, et al.
Publicado: (2017) -
Transcriptional Regulation of Chemokine Expression in Ovarian Cancer
por: Singha, Bipradeb, et al.
Publicado: (2015) -
IKK inhibition increases bortezomib effectiveness in ovarian cancer
por: Singha, Bipradeb, et al.
Publicado: (2015) -
IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL‐8 expression in ovarian cancer cells
por: Gaire, Bijaya, et al.
Publicado: (2023)